UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
11.18
-0.08 (-0.71%)
Apr 29, 2025, 10:34 AM EDT - Market open

UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of $515.33 million as of April 29, 2025. Its market cap has increased by 16.62% in one year.

Market Cap
515.33M
Enterprise Value
398.54M
1-Year Change
16.62%
Ranking
Category
Stock Price
$11.18

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from $167.38M to $515.33M, an increase of 207.89%. That is a compound annual growth rate of 15.13%.

History

DateMarket Cap% Change
Apr 25, 2025454.95M1.23%
Dec 31, 2024449.42M-2.93%
Dec 29, 2023462.99M126.06%
Dec 30, 2022204.81M-3.94%
Dec 31, 2021213.22M-46.44%
Dec 31, 2020398.12M-43.13%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 781.93B
UnitedHealth Group 379.37B
Johnson & Johnson 372.94B
AbbVie 337.49B
Novo Nordisk 272.76B
Abbott Laboratories 224.13B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings